Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India

被引:16
作者
Naveen, Kikkeri Narayanasetty [1 ]
Pai, Varadraj V. [1 ]
Rai, Vijetha [1 ]
Athanikar, Sharatchandra B. [1 ]
机构
[1] Sri Dharmasthala Manjunatheshwara Coll Med Sci &, Dept Dermatol, Dharwad, Karnataka, India
关键词
Anti-epileptics; ofloxacin; Stevens Johnson syndrome; toxic epidermal necrosis; ERYTHEMA MULTIFORME; CAUSATIVE AGENTS; S[!text type='JS']JS[!/text]-10 OVERLAP; DRUG-REACTIONS; CLINICAL TYPES; INPATIENTS; RISK;
D O I
10.4103/0253-7613.106441
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Cutaneous drug reactions are the most common type of adverse drug reactions. Adverse cutaneous drug reactions form 2-3% of the hospitalized patients. 2% of these are potentially serious. This study aims to detect the drugs commonly implicated in Steven Johnson Syndrome-Toxic Epidermal Necrosis (SJS-TEN). Materials and Methods: A retrospective analysis was done in all patients admitted in the last five years in SDM hospital with the diagnosis of SJS-TEN. Results: A total of 22 patients with SJS-TEN were studied. In 11 patients anti-epileptics was the causal drug and in 7, anti-microbials was the causal drug. Recovery was much faster in case of anti epileptics induced SJS-TEN as compared to that induced by ofloxacin. Conclusion: SJS-TEN induced by ofloxacin has a higher morbidity and mortality compared to anti convulsants.
引用
收藏
页码:80 / 82
页数:3
相关论文
共 22 条
[1]  
ALANKO K, 1989, ACTA DERM-VENEREOL, V69, P223
[2]   Drug-induced Stevens-Johnson syndrome (SJS']JS), toxic epidermal necrolysis (TEN), and SJS']JS-TEN overlap: A multicentric retrospective study [J].
Barvaliya, M. ;
Sanmukhani, J. ;
Patel, T. ;
Paliwal, N. ;
Shah, H. ;
Tripathi, C. .
JOURNAL OF POSTGRADUATE MEDICINE, 2011, 57 (02) :115-119
[3]   CLINICAL CLASSIFICATION OF CASES OF TOXIC EPIDERMAL NECROLYSIS, STEVENS-JOHNSON SYNDROME, AND ERYTHEMA MULTIFORME [J].
BASTUJIGARIN, S ;
RZANY, B ;
STERN, RS ;
SHEAR, NH ;
NALDI, L ;
ROUJEAU, JC .
ARCHIVES OF DERMATOLOGY, 1993, 129 (01) :92-96
[4]   Stevens-Johnson syndrome and toxic epidermal necrolysis [J].
Borchers, Andrea T. ;
Lee, Jennifer L. ;
Naguwa, Stanley M. ;
Cheema, Gurtej S. ;
Gershwin, M. Eric .
AUTOIMMUNITY REVIEWS, 2008, 7 (08) :598-605
[5]  
Devi K, 2005, Indian J Dermatol Venereol Leprol, V71, P325
[6]   Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis [J].
Fagot, JP ;
Mockenhaupt, M ;
Bouwes-Bavinck, JN ;
Naldi, L ;
Viboud, C ;
Roujeau, JC .
AIDS, 2001, 15 (14) :1843-1848
[7]   Toxic epidermal necrolysis and Stevens-Johnson syndrome -: Does early withdrawal of causative drugs decrease the risk of death? [J].
Garcia-Doval, I ;
LeCleach, L ;
Bocquet, H ;
Otero, XL ;
Roujeau, JC .
ARCHIVES OF DERMATOLOGY, 2000, 136 (03) :323-327
[8]   Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia [J].
Kamaliah, MD ;
Zainal, D ;
Mokhtar, N ;
Nazmi, N .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1998, 37 (07) :520-523
[9]   Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis [J].
Kardaun, Sylvia H. ;
Jonkman, Marcel F. .
ACTA DERMATO-VENEREOLOGICA, 2007, 87 (02) :144-148
[10]  
KAUPPINEN K, 1984, ACTA DERM-VENEREOL, V64, P320